Position in BCRX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$225,719
+$45,761 QoQ
Shares Held
23,710
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BENDER ROBERT & ASSOCIATES holds $328,756 across 2 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (68.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
23,710 | $225,719 | |
| 2 | EOLS |
Evolus, Inc.
|
25,070 | $103,037 |
All Filings in BCRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225,719 | 23,710 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $179,958 | 23,710 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $212,441 | 23,710 | Shares | Sole | 2025-07-24 | |
| 2024-12-31 | $178,299 | 23,710 | Shares | Sole | 2025-02-07 | |
| 2023-12-31 | $339,034 | 56,600 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $400,728 | 56,600 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $482,944 | 68,600 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $572,124 | 68,600 | Shares | Sole | 2023-04-21 | |
| 2022-09-30 | $864,360 | 68,600 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $725,788 | 68,600 | Shares | Sole | 2022-07-19 | |
| No filing history on record for this holder in this stock. | ||||||